On a very good Friday for the stock market, Biohaven 's ( BHVN 6.33%) performance was exceptional. The clinical-stage biotech ...

CEO Christopher Gibson was one of those sellers, with a Thursday reveal that he had sold 40,390 shares of Recursion's common ...